DDX53 and neoplasm: Extending the above notion further, we performed subcutaneous tumor implantations using shRNA‐mediated Stk24 knockdown cells and observed a substantial reduction of tumor growth in both Stk24‐depleted CT26 (Figure 2E) and KPC cells (Figure 2F).